about
sameAs
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisonsProteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core proteinThe Potential of Plant Phenolics in Prevention and Therapy of Skin DisordersMetalloid compounds as drugsRegulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservationPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibitionNot boring at all. Boron is the new carbon in the quest for novel drug candidatesSelective cytotoxicity of amidinopiperidine based compounds towards Burkitt's lymphoma cells involves proteasome inhibitionThe role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group studyA phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma.Discovery of novel proteasome inhibitors using a high-content cell-based screening systemNew targets for the treatment of follicular lymphoma.Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastomaValidation of a high-content screening assay using whole-well imaging of transformed phenotypes.Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib.A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17.Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.Preferential induction of apoptosis for primary human leukemic stem cells.Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer.Recent advances in proteasome inhibitor discovery.Elapid snake venom analyses show the specificity of the peptide composition at the level of genera Naja and NotechisOverview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.NOB1 is essential for the survival of RKO colorectal cancer cellsIdentification of a molecular target of a novel fungal metabolite, pyrrolizilactone, by phenotypic profiling systems.Proteasome inhibitor patents (2010 - present).Proteasome inhibition: a new anti-inflammatory strategy.Combining proteasome with cell cycle inhibitors: a dual attack potentially applicable to multiple hematopoietic malignancies.Body weight reducing effect of oral boric acid intake.Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-XSynthesis and anti-cancer activities of a water soluble gold(III) porphyrin.Histone deacetylase inhibitors in clinical development.Novel genetic markers of breast cancer survival identified by a genome-wide association study.Proteasome inhibition in hematologic malignancies.
P2860
Q21195237-70EF16FB-0481-4281-A7A4-542380BB00B0Q24297344-7EA2392C-160C-49FE-9BFA-0268A03E96FEQ24301844-350BCBF4-0F72-4EAE-B466-B94A9F8DE15DQ24322067-FC0635E2-B9B1-4817-A903-5E517AB95393Q26768462-35B1525E-FB0A-49E6-B19B-2C32EB357D6CQ26822682-7CB5AE1B-6880-42B7-B969-8925D7B7EBA8Q27000202-71C252E5-5202-4289-A976-AB0B6606D938Q28209990-89559377-9DA0-4846-9A3B-2F7C032B4212Q28281770-45C5E1D6-DD25-4427-9C22-0AD1999409E3Q28307950-B95F365D-D0E1-488F-9CF5-42342414F15EQ28481652-1F8EDF1F-3C19-4300-9699-B5E1A8E48DABQ30248842-34C7C24A-3AFC-4F78-8037-04B012B65EDDQ33394689-CA196926-3719-46B4-8B74-71C4F2BA3D7DQ33398291-9D6DDAFD-F15A-4FB7-9BA3-6EDAEE6AB8ABQ33407672-92E3895E-BF8C-4591-A246-BADA31B133FDQ33521189-A99CBE12-2510-4C2E-8708-4832A5EB28CFQ33587396-EE17EB73-9C48-4AFB-8E2F-E6E9DA0B29FAQ33741854-F305177C-82C4-4A85-B8A1-9A79388100C4Q33779433-80FFBB7F-05A6-4EE0-9CCA-9F2A3408496AQ33903540-7BFA592A-B148-40D3-AA46-B2C820365FC4Q33916030-BE5C5F28-0A86-42BF-9F0F-A694531F74F4Q34080017-3152405F-C1B0-4D91-A631-006904E7828CQ34085167-9AC1419E-CA60-4627-90CC-6B1241293847Q34415832-791DC256-9560-4738-BAB3-FEEE31C3EE0BQ34473291-203B12BB-C721-46F8-B803-5E6421DA77ACQ34513028-4426C2C4-A369-45A0-8988-06CE86646026Q34645067-9E28546A-7A00-460C-B2F9-978FACA3BA51Q34660129-430AEAD1-CD24-4905-B017-42CB1ABFB5C6Q34788381-20E4F1E8-0610-4612-9BF5-381A9DF9303FQ34985999-B4BEDB07-EC2A-49F9-A2D7-155BE7DFB22FQ35027521-8D2E30ED-6D6D-4A81-A20E-E65CADB37627Q35085938-60056CAB-1FA2-4325-AA3B-FC13EE98B79AQ35109750-5274624D-BF36-4A4E-85E0-44BD8170DA08Q35400933-7C5C1C6F-A3D3-49FC-AAF8-53E569ADF23AQ35480383-8CAB030E-968F-42AC-B2F7-30B29837B6F5Q35494324-AF41ECA4-530B-4F3B-87BB-BC93356AFECCQ35530076-262AC667-9926-4CAE-A629-9EF7D634D454Q35609717-DAF4C064-BAF0-4CEA-8DB2-736DE43A909CQ35803492-BAF36A55-D727-4868-8072-C938C8177B63Q35821602-84DB760B-4766-455C-AFFB-B795FD066180
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The proteasome: a novel target for cancer chemotherapy
@ast
The proteasome: a novel target for cancer chemotherapy
@en
The proteasome: a novel target for cancer chemotherapy
@nl
type
label
The proteasome: a novel target for cancer chemotherapy
@ast
The proteasome: a novel target for cancer chemotherapy
@en
The proteasome: a novel target for cancer chemotherapy
@nl
prefLabel
The proteasome: a novel target for cancer chemotherapy
@ast
The proteasome: a novel target for cancer chemotherapy
@en
The proteasome: a novel target for cancer chemotherapy
@nl
P3181
P356
P1433
P1476
The proteasome: a novel target for cancer chemotherapy
@en
P2093
P2888
P304
P3181
P356
10.1038/SJ.LEU.2402417
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1044065576